...
首页> 外文期刊>Cytometry: The Journal of the Society for Analytical Cytology >Algorithms for quantitation of protein expression variation in normal versus tumor tissue as a prognostic factor in cancer: Met oncogene expression, and breast cancer as a model
【24h】

Algorithms for quantitation of protein expression variation in normal versus tumor tissue as a prognostic factor in cancer: Met oncogene expression, and breast cancer as a model

机译:定量评估正常组织与肿瘤组织中蛋白质表达差异作为癌症的预后因素的算法:Met癌基因表达和乳腺癌作为模型

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Immunohistochemistry and immunofluorescence (IF) assays frequently rely on subjective observer evaluation for grading. The aim of our study was to develop an objective quantitative index based on confocal laser scanning microscopy (CLSM) and image analysis of an IF assay to determine alteration in protein expression levels in normal versus tumor tissue. The relative levels of Met expression, a prognostic factor in breast cancer, were used as a model for evaluating image analysis algorithms. Methods: Primary human breast cancer biopsies were collected. Sections containing tumor and adjacent uninvolved normal regions were immunostained for Met and digital images were acquired by CLSM. Subsequently, the digital data were manipulated using several different algorithms to calculate prognostic indexes. The results were correlated with the clinical outcome to determine the prognostic value of these indexes. Results: Different algorithms were used to obtain quantitative indexes to evaluate the relative levels of Met expression. We report a statistical correlation between patient prognosis and relative Met level in normal versus tumor tissue as determined by three distinct algorithms using Kaplan-Meier analysis (log-rank): calculations based on intensity levels differences DV (P = 0.002), DIntensity CP = 0.014), and entropy divergence (Dentropy; P = 0.0023). Conclusions: Using adjacent normal tissue as an internal reference, a quantitative index of tumor Met level divergence can be objectively determined to have a prognostic value. Moreover, this methodology can be used for other proteins in a variety of different diseases. (C) 2000 Wile-Liss, Inc. [References: 29]
机译:背景:免疫组织化学和免疫荧光(IF)分析经常依赖于主观观察者评估来进行评分。我们研究的目的是建立基于共聚焦激光扫描显微镜(CLSM)的客观定量指标和IF分析的图像分析,以确定正常组织与肿瘤组织中蛋白质表达水平的变化。 Met表达的相对水平是乳腺癌的一个预后因素,被用作评估图像分析算法的模型。方法:收集原发性人类乳腺癌活组织检查。对包含肿瘤和相邻未参与正常区域的切片进行Met免疫染色,并通过CLSM获取数字图像。随后,使用几种不同的算法处理数字数据以计算预后指标。结果与临床结果相关,以确定这些指标的预后价值。结果:使用不同的算法获得定量指标,以评估Met表达的相对水平。我们报告了患者预后与正常组织与肿瘤组织中相对Met水平之间的统计相关性,这是通过使用Kaplan-Meier分析(对数秩)的三种不同算法确定的:基于强度水平差DV(P = 0.002),DIntensity CP = 0.014)和熵散度(Dentropy; P = 0.0023)。结论:以邻近的正常组织作为内部参考,可以客观地确定肿瘤Met水平差异的定量指标,具有预后价值。而且,该方法可以用于多种不同疾病中的其他蛋白质。 (C)2000 Wile-Liss,Inc. [参考:29]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号